| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |